Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laura Catherine Cooper is active.

Publication


Featured researches published by Laura Catherine Cooper.


Bioorganic & Medicinal Chemistry Letters | 2001

2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution

Laura Catherine Cooper; Gary G. Chicchi; Kevin Dinnell; Jason Matthew Elliott; Gregory John Hollingworth; Marc M. Kurtz; Karen L Locker; Denise Morrison; Duncan E. Shaw; Kwei-Lan Tsao; Alan P. Watt; Angela R. Williams; Christopher John Swain

The synthesis and biological evaluation of a series of 2-aryl indoles with high affinity for the human neurokinin-1 (hNK1) receptor are reported, concentrating on optimisation of the indole substitution.


Bioorganic & Medicinal Chemistry Letters | 2002

4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II

Jason Matthew Elliott; José L. Castro; Gary G. Chicchi; Laura Catherine Cooper; Kevin Dinnell; Gregory John Hollingworth; Mark Peter Ridgill; Wayne Rycroft; Marc M. Kurtz; Duncan E. Shaw; Christopher John Swain; Kwei-Lan Tsao; Lihu Yang

Abstract A series of novel 4,4-disubstituted cyclohexylamine based NK 1 antagonists is described. The effect of changes to the C 1 –C 4 relative stereochemistry on the cyclohexane ring and replacements for the flexible linker are discussed, leading to the identification of compounds with high affinity and good in vivo duration of action.


Archive | 2003

Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase

Ian Collins; Laura Catherine Cooper; Timothy Harrison; Linda Elizabeth Keown; Andrew Madin; Mark Peter Ridgill


Archive | 2003

Oxadiazole derivatives for inhibition of gamma secretase

Ian Collins; Laura Catherine Cooper


Journal of Medicinal Chemistry | 2009

Novel orally bioavailable γ-secretase inhibitors with excellent in vivo activity

Linda E. Keown; Ian Collins; Laura Catherine Cooper; Andrew Madin; Jayesh Mistry; Michael Reilly; Mohamed Shaimi; Christopher J. Welch; Earl E. Clarke; Huw D. Lewis; Jonathan D. J. Wrigley; Jonathan D. Best; Fraser Murray; Mark S. Shearman


Bioorganic & Medicinal Chemistry Letters | 2007

2,5-Disubstituted pyridines : The discovery of a novel series of 5-HT2A ligands

Kevin J. Wilson; Monique Bodil Van Niel; Laura Catherine Cooper; Dawn Bloomfield; Desmond O’Connor; L. Rebecca Fish; Angus Murray Macleod


Archive | 2007

Diarylsulfones as 5-HT2A antagonists

Jose Luis Castro Pineiro; Laura Catherine Cooper; Myra Gilligan; Alexander Charles Humphries; Peter Hunt; Tamara Ladduwahetty; Angus Murray Macleod; Kevin John Merchant; Monique Bodil Van Niel; Kevin J. Wilson


Bioorganic & Medicinal Chemistry Letters | 2006

Novel lactam NK1 antagonists with anti-emetic activity

Gregory John Hollingworth; Emma J. Carlson; José L. Castro; Gary G. Chicchi; Natalie Clark; Laura Catherine Cooper; Olivier Dirat; Jerry Di Salvo; Jason Matthew Elliott; Ruth Kilburn; Marc M. Kurtz; Wayne Rycroft; F. David Tattersall; Kwei-Lan Tsao; Christopher John Swain


Archive | 2005

Diaryl than 5-HT2A antagonist

Pineiro Jose Luis Castro; Laura Catherine Cooper; Myra Gilligan; Alexander Charles Humphries; Peter Hunt; Tamara Ladduwahetty; Angus Murray Macleod; Kevin John Merchant; Niel Monique Bodil Van; Kevin J. Wilson


Archive | 2005

Diarylsulfone als 5-ht2a-antagonisten Diarylsulfones than 5-HT2A antagonist

Pineiro Jose Luis Castro; Laura Catherine Cooper; Myra Gilligan; Alexander Charles Humphries; Peter Hunt; Tamara Ladduwahetty; Angus Murray Macleod; Kevin John Merchant; Niel Monique Bodil Van; Kevin J. Wilson

Collaboration


Dive into the Laura Catherine Cooper's collaboration.

Researchain Logo
Decentralizing Knowledge